Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce the risk of stroke and deep vein thrombosis.
Medpage Today on MSN22d
First Generics for Low-Dose Rivaroxaban Get FDA ApprovalThe FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.
MyChesCo on MSN18d
FDA Approves Lifesaving Stroke Drug, Xarelto Generics, and Issues Urgent Testosterone WarningsThe U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and significant changes in pharmaceutical labeling, marking advancements in ...
This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.
Half of renally-cleared rivaroxaban is cleared as unchanged drug and half as inactive metabolites. ‡Potent inhibitors of both CYP3A4 and P-gp include azole antifungals (e.g., ketoconazole ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback